Opportunities for nanotechnology-based innovation in tissue proteomics

Biomedical Microdevices

Volumn 6, Issue 3, 2004, Pages 231-239

  Geho, David H ^a   Lahar, Nicholas ^a   Ferrari, Mauro ^b   Petricoin, Emanuel F ^a   Liotta, Lance A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Nanotechnology; Protein micro arrays; Tissue proteomics

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER;

BIOINFORMATICS; CARCINOGENESIS; CLINICAL MEDICINE; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; MOLECULAR WEIGHT; NANOTECHNOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEOMICS; REVIEW;

ANIMALS; HUMANS; MASS SPECTROMETRY; NANOTECHNOLOGY; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TUMOR MARKERS, BIOLOGICAL;

EID: 4544308064     PISSN: 13872176     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BMMD.0000042053.51016.b4     Document Type: Review

References (59)

1. B.L. Adam, Y. Qu, J.W. Davis, M.D. Ward, M.A. Clements, L.H. Cazares, O.J. Semmes, P.F. Schellhammer, Y. Yasui, Z. Feng, and G.L. Wright, Jr., Cancer Res. 62, z3609 (2002).
2. B. Blomback and L. Hanson (eds.), Plasma Proteins (John Wiley and Sons, New York, 1979).
3. P. Blume-Jensen and T. Hunter, Nature 411, 355 (2001).
4. M.N. Bobrow, T.D. Harris, K.J. Shaughnessy, and G.J. Litt, J. Immunol. Methods 125, 279-285 (1989).
5. M.N. Bobrow, K.J. Shaughnessy, and G.J. Litt, J. Immunol. Methods 137, 103-112 (1991).
6. M. Bruchez, Jr., M. Moronne, P. Gin, S. Weiss, and A.P. Alivisatos, Science 281, 2013 (1998).
7. A.J. Carlisle, V.V. Prabhu, A. Elkahloun, J. Hudson, J.M. Trent, W.M. Linehan, E.D. Williams, M.R. Emmert-Buck, L.A. Liotta, P.J. Munson, and D.B. Krizman, Mol. Carcinog. 28, 12 (2000).
8. L. Charboneau, Brief Funct Genomics Proteomics 1, 305 (2002).
9. T.P. Conrads, V.A. Fusaro, S. Ross, D. Johann, V. Rajapakse, B.A. Hitt, S.M. Steinberg, E.C. Kohn, D.A. Fishman, G. Whiteley, J.C. Barrett, L.A. Liotta, E.F. Petricoin, T.D. Veenstra, Endocrine Related Cancer (2004, in press).
10. T.P. Conrads, M. Zhou, E.F. Petricoin, III, L. Liotta, and T.D. Veenstra, Expert Rev. Mol. Diagn. 3, 411 (2003).
11. D.H. Davis, C.S. Giannoulis, R.W. Johnson, and T.A. Desai, Biomaterials 23, 4019 (2002).
12. T. Desai, D. Hansford, L. Kulinsky, A.H. Nashat, G. Rasi, J. Tu, Y. Wang, M. Zhang, and M. Ferrari, Biomedical Microdevices 2, 11 (1999).
13. T.A. Desai, D.J. Hansford, L. Leoni, M. Essenpreis, and M. Ferrari, Biosensors and Bioelectronics 15, 453 (2000).
14. M.R. Emmert-Buck, R.F. Bonner, P.D. Smith, R.F. Chuaqui, Z. Zhuang, S.R. Goldstein, R.A. Weiss, and L.A. Liotta, Science 274, 998 (1996).
15. M.R. Emmert-Buck, R.L. Strausberg, D.B. Krizman, M.F. Bonaldo, R.F. Bonner, D.G. Bostwick, MR. Brown, K.H. Buetow, R.F. Chuaqui, K.A. Cole, et al., J. Mol. Diagn. 2, 60 (2000).
16. V. Espina, A.I. Mehta, M.E. Winters, V. Calvert, J. Wulfkuhle, E.F. Petricoin, 3rd, and L.A. Liotta, Proteomics 3, 2091 (2003).
17. D.H. Geho, E.F. Petricoin, and L.A. Liotta, Clin. Cancer Res. 10, 825 (2004).
18. D.S. Ginger, H. Zhang, and C.A. Mirkin, Angew Chem. Int. Ed. Engl. 43, 30 (2004).
19. R. Graf and P. Friedl, Anal. Biochem. 273, 291 (1999).
20. R.L. Grubb, V.S. Calvert, J.D. Wulkuhle, C.P. Paweletz, W.M. Linehan, J.L. Phillips, R. Chuaqui, A. Valasco, J. Gillespie, M. Emmert-Buck, et al., Proteomics 3, 2142 (2003).
21. M. Han, X. Gao, J.Z. Su, and S. Nie, Nat. Biotechnol 19, 631 (2001).
22. S.R. Hingorani, E.F. Petricoin, A. Maitra, V. Rajapakse, C. King, M.A. Jacobetz, S. Ross, T.P. Conrads, T.D. Veenstra, B.A. Hitt, et al., Cancer Cell 4, 437 (2003).
23. S. Howorka, S. Cheley, and H. Bayley, Nat. Biotechnol. 19, 636 (2001).
24. B. Hunyady, K. Krempels, G. Harta, and E. Mezey, J. Histochem. Cytochem. 44, 1353 (1996).
25. G. King, S. Payne, F. Walker, and G.I. Murray, J. Pathol. 183, 237 (1997).
26. V. Knezevic, C. Leethanakul, V.E. Bichsel, J.M. Worth, V.V. Prabhu, J.S. Gutkind, L.A. Liotta, P.J. Munson, E.F. Petricoin, 3rd, and D.B. Krizman, Proteomics 1, 1271 (2001).
27. S.P. Lal, R.I. Christopherson, and C.G. dos Remedios, Drug Discov. Today 7, S143-149 (2002).
28. J. Li, Z. Zhang, J. Rosenzweig, Y.Y. Wang, and D.W. Chan, Clin. Chem. 48, 1296 (2002).
29. L. Liotta and E. Petricoin, Nat. Rev. Genet. 1, 48 (2000).
30. L.A. Liotta, V. Espina, A.I. Mehta, V. Calvert, K. Rosenblatt, D. Geho, P.J. Munson, L. Young, J. Wulfkuhle, and E.F. Petricoin, Cancer Cell 3, 317 (2003a).
31. L.A. Liotta, M. Ferrari, and E. Petricoin, Nature 425, 905 (2003b).
32. L.A. Liotta and E.C. Kohn, Nature 411, 375 (2001).
33. L.A. Liotta, E.C. Kohn, and E.F. Petricoin, JAMA 286, 2211 (2001).
34. A.I. Mehta, S. Ross, M. Lowenthal, V.A. Fusaro, D.A. Fishman, E. Petricoin, and L. Liotta, Disease Markers 19, 1 (2003).
35. A. Meller, L. Nivon, E. Brandin, J. Golovchenko, and D. Branton, Proc. Natl Acad. Sci. USA 97, 1079 (2000).
36. A.H. Nashat, M. Moronne, and M. Ferrari, Biotechnol. Bioeng. 60, 137 (1998).
37. J.M. Nam, C.S. Thaxton, and C.A. Mirkin, Science 301, 1884 (2003).
38. S.R. Nicewarner-Pena, R.G. Freeman, B.D. Reiss, L. He, D.J. Pena, I.D. Walton, R. Cromer, C.D. Keating, and M.J. Natan, Science 294, 137 (2001).
39. D.K. Ornstein, J.W. Gillespie, C.P. Paweletz, P.H. Duray, J. Herring, C.D. Vocke, S.L. Topalian, D.G. Bostwick, W.M. Linehan, E.F. Petricoin, 3rd, and MR. Emmert-Buck, Electrophoresis 21, 2235 (2000).
40. C.P. Paweletz, L. Charboneau, V.E. Bichsel, N.L. Simone, T. Chen, J.W. Gillespie, M.R. Emmert-Buck, M.J. Roth, I.E. Petricoin, and L.A. Liotta, Oncogene 20, 1981 (2001).
41. C.P. Paweletz, J.W. Gillespie, D.K. Ornstein, N.L. Simone, M.R. Brown, K.A. Cole, Q.H. Wang, J. Huang, N. Hu, T.T. Yip, W.E. Rich, E.C. Kohn, W.M. Linehan, T. Weber, P. Taylor, M.R. Emmert-Buck, L.A. Liotta, and E.F. Petricoin, III, Drug Develop. Res. 49, 34 (2000).
42. T. Pawson, Nature 373, 573 (1995).
43. E. Petricoin, D.A. Fishman, T.P. Conrads, T.D. Veenstra, and L. Liotta, Proteomic Pattern Diagnostics: Producers and Consumers in the Era of Correlative Science. BMC Bioinformatics Posted March 12, 2004 (2004). (http://www.biomedcentral.com/1471-2105/4/24/comments).
44. E.F. Petricoin, III, D.K. Ornstein, C.P. Paweletz, A. Ardekani, P.S. Hackett, B.A. Hitt, A. Velassco, C. Trucco, L. Wiegand, K. Wood, et al., J. Natl. Cancer Inst. 94, 1576 (2002a).
45. E.F. Petricoin, A.M. Ardekani, B.A. Hitt, P.J. Levine, V.A. Fusaro, S.M. Steinberg, G.B. Mills, C. Simone, D.A. Fishman, E.C. Kohn, and L.A Liotta, Lancet 359, 572 (2002b).
46. E.F. Petricoin and L.A. Liotta, Clin. Chem. 49, 533 (2003).
47. E.F. Petricoin, K.C. Zoon, E.C. Kohn, J.C. Barrett, and L.A. Liotta, Nat. Rev. Drug Discov. 1, 683 (2002c).
48. K.P. Rosenblatt, P. Bryant-Greenwood, J.K. Killian, A. Mehta, D. Geho, V. Espina, E.F. Petricoin, III, and L.A. Liotta, Annu. Rev. Med. 55, 97 (2004).
49. S.A. Schwartz, R.J. Weil, M.D. Johnson, S.A. Toms, and R.M. Caprioli, Clin. Cancer Res. 10, 981 (2004).
50. H. Shi and B.D. Ratner, J. Biomed. Mater. Res. 49, 1 (2000).
51. B.A. Stillman and J.L. Tonkinson, Biotechniques 29, 630 (2000).
52. M. Stoeckli, P. Chaurand, D.E. Hallahan, and R.M. Caprioli, Nat. Med. 7, 493 (2001).
53. M.F. Templin, D. Stoll, M. Schrenk, P.C. Traub, C.F. Vohringer, and T.O. Joos, Trends Biotechnol. 20, 160 (2002).
54. R.S. Tirumalai, K.C. Chan, D.A. Prieto, H.J. Issaq, T.P. Conrads, and T.D. Veenstra, Mol. Cell Proteomics 2, 1096 (2003).
55. J.L. Tonkinson and B.A. Stillman, Front Biosci. 7, c1 (2002).
56. H. Wang and D. Branton, Nat. Biotechnol. 19, 622-623 (2001).
57. J.D. Wulfkuhle, J.A. Aquino, V.S. Calvert, D.A. Fishman, G. Coukos, L.A. Liotta, and E.F. Petricoin, III, Proteomics 3, 2085 (2003).
58. K. Yanagisawa, Y. Shyr, B.J. Xu, P.P. Massion, P.H. Larsen, B.C. White, J.R. Roberts, M. Edgerton, A. Gonzalez, S. Nadaf, et al., Lancet 362, 433 (2003).
59. M. Zhang, T Desai, and M. Ferrari, Biomaterials 19, 953-960 (1998).